Literature DB >> 3435830

Organization of efferent projections of the subthalamic nucleus in the squirrel monkey as revealed by retrograde labeling methods.

A Parent1, Y Smith.   

Abstract

The cellular origin and degree of collateralization of the subthalamostriatal, subthalamonigral and subthalamopallidal projections in the squirrel monkey (Saimiri sciureus) were studied using lectin-conjugated horseradish peroxidase (WGA-HRP), Nuclear yellow (NY) and Fast blue (FB) as retrograde tracers. In a first experimental group, WGA-HRP was injected in the left putamen and the right caudate nucleus. Following these injections numerous retrogradely labeled neurons occurred in the dorsolateral two-thirds of the subthalamic nucleus on the putamen-injected side, whereas a smaller number of positive cells were found in the ventromedial third of the same nucleus on the caudate-injected side. In a second experimental group NY was injected in the putamen whereas FB was delivered in the substantia nigra on the same side of the brain. After putaminonigral injections subthalamic cells containing the tracer injected in the putamen (about 75-80% of all retrogradely labeled neurons) occurred in the dorsolateral two-thirds of the nucleus, whereas those containing the tracer injected in the substantia nigra (about 20-25% of all positive subthalamic cells) were confined to the ventromedial third of the structure. Approximately 5-10% of all subthalamic positive neurons were double-labeled following putaminonigral injections. In a third experimental group, NY was injected in the caudate nucleus and FB in the substantia nigra on the same side. After such injections cells retrogradely labeled with NY or FB were present in about equal number and appeared closely intermingled in the ventromedial third of the subthalamic nucleus. Less than 10% of all positive subthalamic neurons were double-labeled following caudatonigral injections. In a fourth experimental group, NY was delivered in the globus pallidus and FB in the substantia nigra on the same side. In these animal cells containing the tracer delivered in the pallidum were about 4 times more numerous than those labeled with the tracer injected in the substantia nigra, and approximately 10-20% of all positive subthalamic neurons were double-labeled following pallidonigral injections. Most of these double-labeled cells occurred in the zone where the two populations of single-labeled cells overlapped. Finally, in a last experimental group, NY was injected in the pedunculopontine nucleus on one side and in the substantia nigra on the other. Following these injections cells containing the tracer delivered in the pedunculopontine nucleus were found to be 5-6 times less numerous than those labeled after substantia nigra injections...

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435830     DOI: 10.1016/0006-8993(87)91674-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  26 in total

1.  Short and long-term changes in cerebral [14C]-2-deoxyglucose uptake in the MPTP-treated marmoset: relationship to locomotor activity.

Authors:  K K Gnanalingham; N A Milkowski; L A Smith; A J Hunter; P Jenner; C D Marsden
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  A biologically constrained model of the whole basal ganglia addressing the paradoxes of connections and selection.

Authors:  Jean Liénard; Benoît Girard
Journal:  J Comput Neurosci       Date:  2014-06       Impact factor: 1.621

3.  Activity of neurons of the subthalamic nucleus in relation to motor performance in the cat.

Authors:  F Cheruel; J F Dormont; D Farin
Journal:  Exp Brain Res       Date:  1996-03       Impact factor: 1.972

4.  The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines.

Authors:  Reka Natarajan; Bryan K Yamamoto
Journal:  Basal Ganglia       Date:  2011-07-01

Review 5.  Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?

Authors:  Thomas Wichmann; Mahlon R DeLong
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

6.  Parvalbumin+ and Npas1+ Pallidal Neurons Have Distinct Circuit Topology and Function.

Authors:  Arin Pamukcu; Qiaoling Cui; Harry S Xenias; Brianna L Berceau; Elizabeth C Augustine; Isabel Fan; Saivasudha Chalasani; Adam W Hantman; Talia N Lerner; Simina M Boca; C Savio Chan
Journal:  J Neurosci       Date:  2020-08-31       Impact factor: 6.167

Review 7.  Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Rosalinda C Roberts
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

8.  Contemporaneous bilateral postero-ventral pallidotomy for early onset "juvenile type" Parkinson's disease. Case report.

Authors:  R P Iacono; R R Lonser; S Yamada
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

9.  Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia.

Authors:  Pedro Barroso-Chinea; Erwan Bezard
Journal:  Front Neuroanat       Date:  2010-09-14       Impact factor: 3.856

10.  Cerebellar loops with motor cortex and prefrontal cortex of a nonhuman primate.

Authors:  Roberta M Kelly; Peter L Strick
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.